Nisa Investment Advisors, LLC Provention Bio, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$6.7 - $24.21 $8,174 - $29,536	1,220 Added 1906.25%	1,284 $31,000
Q4 2022 Feb 02, 2023	BUY	$4.52 - $10.57 $289 - $676	64 New	64 $1,000
Q2 2022 Aug 03, 2022	SELL	$3.65 - $7.3 $165,710 - $331,420	-45,400 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$3.4 - $7.88 $154,360 - $357,752	45,400 New	45,400 $332,000
Q3 2021 Oct 18, 2021	SELL	$5.66 - $8.33 $28,866 - $42,483	-5,100 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$6.71 - $11.04 $34,221 - $56,303	5,100 New	5,100 $43,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.